Bydureon BCise 2 mg/0.85 mL prefilled autoinjector Images
Generic Name: exenatide
This medication has been identified as Bydureon BCise 2 mg/0.85 mL prefilled autoinjector. It is supplied by AstraZeneca.
Bydureon BCise is used in the treatment of Diabetes, Type 2 and belongs to the drug class Incretin Mimetics (GLP-1 Agonists). Risk cannot be ruled out during pregnancy. Bydureon BCise 2 mg/0.85 mL prefilled autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bydureon BCise
- Generic Name
- exenatide
- Strength
- 2 mg/0.85 mL prefilled autoinjector
- Availability
- Prescription only
- Drug Class
- Incretin Mimetics (GLP-1 Agonists)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-6540
More about Bydureon BCise (exenatide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: Incretin Mimetics (GLP-1 Agonists)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
